Drug Profile
Research programme: AgRP inhibitors - vTv Therapeutics
Alternative Names: HPP 515; TTP 2515; TTP 515Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator TransTech Pharma
- Developer vTv Therapeutics LLC
- Class Small molecules
- Mechanism of Action Agouti-related protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Female sexual dysfunction; Obesity
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Female-sexual-dysfunction in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in USA (PO)
- 20 May 2005 The programme is available for licensing (http://www.ttpharma.com)